BRAF V600E screening identifies candidates for perioperative therapy
Skip to content
The CRC Digest
BRAF V600E screening identifies candidates for perioperative therapy
Multicenter screening evaluated preoperative BRAF V600E mutation detection in patients with resectable colorectal oligometastases, enabling recruitment to a trial of the BEACON triplet regimen. (Int J Clin Oncol)
This content is informational only and does not